Treatment patterns by predictive biomarker testing (<i>EGFR</i> mutation and <i>ALK</i> rearrangement) and mutation status for patients with nonsquamous NSCLC in Japan, Korea, Taiwan, and Brazil.
收藏NIAID Data Ecosystem2026-03-10 收录
数据链接：
官方服务：
资源简介：
Treatment patterns by predictive biomarker testing (EGFR mutation and ALK rearrangement) and mutation status for patients with nonsquamous NSCLC in Japan, Korea, Taiwan, and Brazil.
创建时间：
2018-08-27
